Aerovate Therapeutics (AVTE) executive Gillies sold 511 shares for $9,965 at $19.50 under a 10b5-1 plan
Insider transactions reported
Hunter Gillies (Chief Medical Officer at Aerovate Therapeutics Inc., AVTE) reported that they sold 511 shares for $9,965 at $19.50, and acquired 511 shares at $1.74 on Feb 23, 2024. After these transactions the filing shows 3,251 shares held directly.
- Reporting person
- Gillies Hunter
- Role
- CHIEF MEDICAL OFFICER
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 23, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +511 | $1.74 | $889 | 3,762 direct |
| Feb 23, 2024 | Open-market sale (S) | Common Stock1 | -511 | $19.50 | $9,965 | 3,251 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 23, 2024 | Exercise or conversion of a derivative (M) | Stock Option (Right to Buy)On 511 Common Stock1, 2 | -511 | - | - | 3,014 direct |
Holdings before and after
- Stock Option (Right to Buy): 3,525 to 3,014 direct
Footnotes from the filing
- 1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
- 2. A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Gillies report in this AVTE Form 4?
Hunter Gillies (Chief Medical Officer at Aerovate Therapeutics Inc., AVTE) reported that they sold 511 shares for $9,965 at $19.50, and acquired 511 shares at $1.74 on Feb 23, 2024. After these transactions the filing shows 3,251 shares held directly.
How many AVTE shares does Gillies hold after this filing?
The filing shows 3,251 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this AVTE insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for AVTE
Earlier insider filings at AVTE
- Feb 22, 2024Gillies Hunter exercised 3,489 shares at a strike of $1.74 and sold $70,575 worth of shares (3,489 units at $20.23) (SEC Form 4)
- Feb 7, 2024Niven Ralph exercised 4,600 shares at a strike of $2.02 and sold $80,249 worth of shares (4,600 units at $17.45) (SEC Form 4)
- Jan 31, 2024SEC Form 4 filed by Noyes Timothy P
- Jan 24, 2024SEC Form 4 filed by Pigot Timothy
- Jan 24, 2024SEC Form 4 filed by Gillies Hunter
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Follow AVTE and get a push notification the moment its next story breaks.